Khose And Khose Biotech Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 16 Year, 5 Months
- Last Filing with ROC 31 Mar 2022
- Satisfied Charges ₹ 1.00 M
About Khose And Khose Biotech
Khose And Khose Biotech Private Limited (KAKBPL) is a Private Limited Indian Non-Government Company incorporated in India on 24 September 2008 and has a history of 16 years and five months. Its registered office is in Pune, Maharashtra, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M.
The company has closed loans amounting to ₹1.00 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Sanjay Khose and Bhagyashri Khose serve as directors at the Company.
Company Details
- Location
Pune, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U01122PN2008PTC132819
- Company No.
132819
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Sep 2008
- Date of AGM
30 Sep 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Pune
Industry
Who are the key members and board of directors at Khose And Khose Biotech?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sanjay Khose  | Director | 24-Sep-2008 | Current |
| Bhagyashri Khose | Director | 30-Sep-2016 | Current |
Financial Performance of Khose And Khose Biotech.
Khose And Khose Biotech Private Limited, for the financial year ended 2017, experienced no change in revenue, with a 0% increase. The company also saw a no change in profitability, with a 0% increase in profit. The company's net worth witnessed no change by increase of 0%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Khose And Khose Biotech?
In 2017, Khose And Khose Biotech had a promoter holding of 67.00% and a public holding of 33.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Khose And Khose Limited Liability Partne RshipSanjay Khose and Bhagyashri Khose are mutual person
- Orion Brainworks Private Limited
Sanjay Khose and Bhagyashri Khose are mutual person
Charges (Loans)
₹0
₹1.00 M
Charges Breakdown by Lending Institutions
- Pune People'S Co- Operative Bank Ltd. : 0.10 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 26 Nov 2009 | Pune People's Co- Operative Bank Ltd. | ₹1.00 M | Satisfied |
How Many Employees Work at Khose And Khose Biotech?
Unlock and access historical data on people associated with Khose And Khose Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Khose And Khose Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Khose And Khose Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.